Lynsey Howard

Dr Lynsey Howard has over 10 years of experience in the strategy, design and implementation of innovative biopharmaceutical R&D along with team leadership, business development and senior management.

Lynsey originally completed her BSc (hons) in Virology from the University of Glasgow, where she subsequently completed a PhD in novel stem cell and gene therapies for cardiovascular disease within the Institute of Cardiovascular and Medical Sciences. Following this, Lynsey took up a Post-Doctoral Researcher position at the University of Bristol working in the Bristol Heart Institute.

Prior to joining EnteroBiotix, Lynsey was Head of Preclinical Research and Development at Lamellar Biomedical where she created extensive internal and external scientific capability in infection biology, antimicrobial development, respiratory disease, gene therapy, and immunology. Lynsey directed several collaborations with world-leading institutes and commercial partners, as well as led an in-house team of multidisciplinary scientists. Lynsey’s work generated valuable intellectual property for Lamellar, resulting in 5 patent submissions.